Published in Genome Med on August 30, 2017
dbSNP: the NCBI database of genetic variation. Nucleic Acids Res (2001) 76.97
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
A census of human cancer genes. Nat Rev Cancer (2004) 36.20
Cancer genome landscapes. Science (2013) 25.33
GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol (2010) 16.72
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature (2005) 15.28
Mutational landscape and significance across 12 major cancer types. Nature (2013) 14.91
Annotation of functional variation in personal genomes using RegulomeDB. Genome Res (2012) 11.47
COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res (2014) 10.77
The transcriptional network for mesenchymal transformation of brain tumours. Nature (2009) 8.44
Highly recurrent TERT promoter mutations in human melanoma. Science (2013) 8.40
TERT promoter mutations in familial and sporadic melanoma. Science (2013) 7.82
A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet (2003) 6.82
FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N Engl J Med (2015) 6.48
Emerging landscape of oncogenic signatures across human cancers. Nat Genet (2013) 6.48
Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep (2013) 3.92
Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A (2007) 3.84
Choosing the right cell line for breast cancer research. Breast Cancer Res (2011) 3.57
In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell (2015) 3.56
ETS transcription factors and their emerging roles in human cancer. Eur J Cancer (2005) 3.55
Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature (2016) 3.05
Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science (2014) 2.91
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90
Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet (2014) 2.86
TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis. Nucleic Acids Res (2005) 2.68
Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell (2014) 2.60
Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res (2009) 2.04
Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin Cell Dev Biol (2009) 1.78
Predicting effects of noncoding variants with deep learning-based sequence model. Nat Methods (2015) 1.72
Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer. Genome Res (2014) 1.63
Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology (2007) 1.58
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL. Nat Med (2012) 1.56
Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene (2000) 1.55
A method to predict the impact of regulatory variants from DNA sequence. Nat Genet (2015) 1.51
Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling. J Biol Chem (2009) 1.44
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer. Genome Biol (2014) 1.36
ETS transcription factors in endocrine systems. Trends Endocrinol Metab (2007) 1.33
Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression. Nature (2016) 1.25
Overexpression of the Ets-1 transcription factor in human breast cancer. Br J Cancer (2004) 1.20
A Compendium of Chromatin Contact Maps Reveals Spatially Active Regions in the Human Genome. Cell Rep (2016) 1.18
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat Commun (2015) 1.10
Role of non-coding sequence variants in cancer. Nat Rev Genet (2016) 1.10
Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem (2007) 1.07
Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype. Oncogene (2013) 1.01
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell (2014) 0.99
Ets transcription factors in intestinal morphogenesis, homeostasis and disease. Histol Histopathol (2008) 0.98
Identification of altered cis-regulatory elements in human disease. Trends Genet (2015) 0.97
Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells. BMC Genomics (2014) 0.94
MBASED: allele-specific expression detection in cancer tissues and cell lines. Genome Biol (2014) 0.93
Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas. Genome Biol (2015) 0.90
Cancer: Mutations close in on gene regulation. Nature (2013) 0.90
i-cisTarget 2015 update: generalized cis-regulatory enrichment analysis in human, mouse and fly. Nucleic Acids Res (2015) 0.90
Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells. Int J Gynecol Cancer (2013) 0.90
Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models. PLoS Comput Biol (2015) 0.90
OncoCis: annotation of cis-regulatory mutations in cancer. Genome Biol (2014) 0.89
A novel role for signal transducer and activator of transcription 5b (STAT5b) in beta1-integrin-mediated human breast cancer cell migration. Breast Cancer Res (2009) 0.88
GeneAnalytics: An Integrative Gene Set Analysis Tool for Next Generation Sequencing, RNAseq and Microarray Data. OMICS (2016) 0.87
The role of enhancers in cancer. Nat Rev Cancer (2016) 0.84
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer. BMC Cancer (2015) 0.79
APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL. Leukemia (2017) 0.77